Search Results - "Savolainen, MJ"

Refine Results
  1. 1

    Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide by Astrup, A, Carraro, R, Finer, N, Harper, A, Kunesova, M, Lean, M E J, Niskanen, L, Rasmussen, M F, Rissanen, A, Rössner, S, Savolainen, M J, Van Gaal, L

    Published in International Journal of Obesity (01-06-2012)
    “…Objective: Having demonstrated short-term weight loss with liraglutide in this group of obese adults, we now evaluate safety/tolerability (primary outcome) and…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5

    Metabolic changes induced by peroral oestrogen and transdermal oestradiol gel therapy by Karjalainen, A., Heikkinen, J., Savolainen, M. J., Bäckström, A‐C., Salinto, M., Kesäniemi, Y. A.

    “…Objective To investigate changes in plasma lipid and lipoprotein levels induced by peroral oestrogen replacement and transdermal oestradiol gel therapy. Design…”
    Get full text
    Journal Article
  6. 6
  7. 7

    High vitreous concentration of IL-6 and IL-8, but not of adhesion molecules in relation to plasma concentrations in proliferative diabetic retinopathy by Koskela, U E, Kuusisto, S M, Nissinen, A E, Savolainen, M J, Liinamaa, M J

    Published in Ophthalmic research (01-01-2013)
    “…Inflammatory markers have been observed in proliferative diabetic retinopathy (PDR). We assessed vitreous concentrations of adhesion molecules and cytokines in…”
    Get more information
    Journal Article
  8. 8
  9. 9
  10. 10

    A 4-fold risk of metabolic syndrome in patients with schizophrenia : The Northern Finland 1966 birth cohort study by SAARI, Kaisa M, LINDEMAN, Sari M, VIILO, Kaisa M, ISOHANNI, Matti K, JÄRVELIN, Marjo-Riitta, LAUREN, Liisa H, SAVOLAINEN, Markku J, KOPONEN, Hannu J

    Published in The journal of clinical psychiatry (01-05-2005)
    “…Schizophrenia is associated with a shortened life expectancy and increased somatic comorbidity with, e.g., cardiovascular disorders. One major risk factor for…”
    Get full text
    Journal Article
  11. 11

    Reduction in the concentration and activity of plasma cholesteryl ester transfer protein by alcohol by Hannuksela, M, Marcel, YL, Kesäniemi, YA, Savolainen, MJ

    Published in Journal of lipid research (01-05-1992)
    “…Plasma cholesteryl esters, synthesized within high density lipoproteins (HDL), may be transferred from HDL particles to other lipoproteins by plasma…”
    Get full text
    Journal Article
  12. 12
  13. 13

    High-density lipoprotein increases the abundance of eNOS protein in human vascular endothelial cells by increasing its half-life by Rämet, Maria E, Rämet, Mika, Lu, Qing, Nickerson, Moriah, Savolainen, Markku J, Malzone, Amy, Karas, Richard H

    “…Given the importance of endothelial nitric oxide synthase (eNOS) in regulating endothelium-dependent vasorelaxation, we investigated the effects of…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Low plasma antibodies specific for phosphatidylethanol in alcohol abusers and patients with alcoholic pancreatitis by Nissinen, Antti E., Laitinen, L. Maria, Kakko, Sakari, Helander, Anders, Savolainen, Markku J., Hörkkö, Sohvi

    Published in Addiction biology (01-11-2012)
    “…ABSTRACT Phosphatidylethanol (PEth) is a group of alcohol‐modified phospholipids present in cell membranes after heavy drinking. Our aim was to demonstrate the…”
    Get full text
    Journal Article
  17. 17

    The effects of interleukin‐8, VEGF and CFH polymorphisms on the long‐term response to bevacizumab therapy in exudative age‐related macular degeneration by HAUTAMäKI, A, KIVIOJA, J, VAVULI, S, KAKKO, S, SAVOLAINEN, ER, SAVOLAINEN, MJ, LIINAMAA, MJ, SEITSONEN, S, ONKAMO, P, JÄRVELÄ, I, LUOMA, A, IMMONEN, I

    Published in Acta ophthalmologica (Oxford, England) (01-08-2013)
    “…Purpose To study the effects of IL‐8, VEGF, CFH, complement component C3 and LOC387715 single nucleotide polymorphisms and neovascular lesion characteristics…”
    Get full text
    Journal Article
  18. 18

    Ghrelin Arg51Gln mutation is a risk factor for Type 2 diabetes and hypertension in a random sample of middle-aged subjects by PÖYKKÖ, S, UKKOLA, O, KAUMA, H, SAVOLAINEN, M. J, KESÄNIEMI, Y. A

    Published in Diabetologia (01-04-2003)
    “…Experimental studies have suggested that ghrelin, a novel gastrointestinal peptide hormone, could play a role in glucose homeostasis. In addition, ghrelin has…”
    Get full text
    Journal Article
  19. 19

    Prevalence of the metabolic syndrome in drug‐treated hypertensive patients and control subjects by Rantala, A. O., Kauma, H., Lilja, M., Savolainen, M. J., Reunanen, A., Kesäniemi, Y. A.

    Published in Journal of internal medicine (01-02-1999)
    “…Objectives. To determine the prevalence of the metabolic abnormalities associated with hypertension and to define the predictors of the metabolic syndrome by…”
    Get full text
    Journal Article
  20. 20

    Gamma‐glutamyl transpeptidase and the metabolic syndrome by Rantala, A. O., Lilja, M., Kauma, H., Savolainen, M. J., Reunanen, A., Kesäniemi, Y. A.

    Published in Journal of internal medicine (01-09-2000)
    “… Rantala AO, Lilja M, Kauma H, Savolainen MJ, Reunanen A, Kesäniemi YA (University of Oulu, Oulu; and The National Public Health Institute, Helsinki,…”
    Get full text
    Journal Article